The Boring Company released both an Environmental Impact Assessment and a letter of review from an independent third party on ...

The FDA approved niraparib and abiraterone acetate (Akeega) in combination with prednisone for treating BRCA2 -mutated ...

The study presents convincing quantitative evidence, supported by appropriate negative controls, for the presence of low-abundance glycine receptors (GlyRs) within inhibitory synapses in telencephalic ...

The agency said that although Akeega with prednisone improved outcomes in all patients with HRR mutations, the benefits were driven by those with BRCA2 mutations.

The FDA has greenlit niraparib and abiraterone acetate (AAP; Akeega) with prednisone for the treatment of adults with deleterious or suspected deleterious BRCA2 -mutated metastatic hormone-sensitive ...

Novo Nordisk has officially launched Ozempic (injectable semaglutide) in India, marking the arrival of one of the most widely used once-weekly GLP-1 receptor agonists for adults with uncontrolled type ...